Clairyon Inc., a leader in clinical artificial intelligence and healthcare automation, today announced the publication of a ...
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center We performed cluster random ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results